orally available fetal hemoglobin inducer

oral induction of fetal hemoglobal in cyno

from phenotypic screen and ADME opt.

Bioorg. Med. Chem. Lett., Jul. 24, 2020

Daiichi-Sankyo, Tokyo, JP / Asubio

Structure of compound 18

“compound 18” is an oral inducer of fetal hemoglobin (HbF) intended to treat anemias such as sickle cell disease and beta-thalassemia. The authors identified a weak hit (>10 uM) from…

get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: